Bispecific antibodies companies

Companies

• Amgen FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Thousand Oaks, CA · Biosimilars, Bispecific antibodies, Gene therapy · 1686 jobs observed · 1043 trials (lead sponsor)

• Merck & Co., Inc. FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Rahway, NJ · Antibody-drug conjugates (ADC), Biosimilars, Bispecific antibodies · 939 jobs observed · 1369 trials (lead sponsor)

• Bristol-Myers Squibb FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Bispecific antibodies, Cell therapy, Cell therapy: CAR-T · 712 jobs observed · 1560 trials (lead sponsor)

• Biogen FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Antisense oligonucleotides, Bispecific antibodies, Monoclonal antibodies · 260 jobs observed · 509 trials (lead sponsor)

• Coherus Oncology Clinical Phase 3

  Bispecific antibodies · 6 jobs observed · 18 trials (lead sponsor)

• Sutro Biopharma Clinical Phase 3

  South San Francisco, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · 5 jobs observed · 8 trials (lead sponsor)

• Shennon Biotechnologies

  San Francisco, CA · Bispecific antibodies · 1,746 jobs observed

• TwoStep Therapeutics Clinical Phase 1

  San Carlos, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Radiopharma · 1 job observed · 1 trial (lead sponsor)

• Aakha Biologics

  Frisco, TX · Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Abpro

  Burlington, MA · Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Adaptin Bio

  Charlotte, NC · Bispecific antibodies · No hiring observed in our sources

• Adimab

  Lebanon, NH · Bispecific antibodies, Monoclonal antibodies, Proteins / enzymes · No hiring observed in our sources

• Antigenix Therapeutics

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Apeximmune Therapeutics Inc.

  South San Francisco, CA · Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Aptevo Therapeutics Clinical Phase 2

  Seattle, WA · Bispecific antibodies · No hiring observed in our sources · 9 trials (lead sponsor)

• ATUM

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Bambusa Therapeutics Clinical Phase 2

  Bispecific antibodies · No hiring observed in our sources · 6 trials (lead sponsor)

• BioAtla, Inc. Clinical Phase 2

  San Diego, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 6 trials (lead sponsor)

• Biohaven Clinical Phase 3

  New Haven, CT · Antibody-drug conjugates (ADC), Bispecific antibodies, Small molecule · No hiring observed in our sources · 34 trials (lead sponsor)

• BiOneCure Therapeutics Inc.

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• BioNTech US Inc. Clinical Phase 3

  Bispecific antibodies, Diagnostics, Diagnostics: molecular · No hiring observed in our sources · 74 trials (lead sponsor)

• Boehringer Ingelheim FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Bispecific antibodies, Digital health, Drug delivery / formulation · No hiring observed in our sources · 2297 trials (lead sponsor)

• Candel Therapeutics, Inc. Clinical Phase 3

  Needham, MA · Bispecific antibodies, Gene therapy, Oncolytic viruses · No hiring observed in our sources · 13 trials (lead sponsor)

• Celldex Therapeutics Clinical Phase 3

  New Haven, CT · Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 45 trials (lead sponsor)

• Context Therapeutics Clinical Phase 2

  Philadelphia, PA · Bispecific antibodies · No hiring observed in our sources · 5 trials (lead sponsor)

• Cullinan Therapeutics Inc. Clinical Phase 2

  Cambridge, MA · Bispecific antibodies · No hiring observed in our sources · 12 trials (lead sponsor)

• Cypre

  San Francisco, CA · Antibody-drug conjugates (ADC), Bispecific antibodies · No hiring observed in our sources

• Daiichi Sankyo FDA-approved therapeutic company Clinical Phase 3

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 393 trials (lead sponsor)

• Diagonal Therapeutics Clinical Phase 2

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 1 trial (lead sponsor)

• Dren Bio Clinical Phase 2

  San Carlos, CA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 7 trials (lead sponsor)

• Drive Therapeutics, LLC

  Bispecific antibodies · No hiring observed in our sources

• Eitr Biologics, Inc.

  San Diego, CA · Bispecific antibodies · No hiring observed in our sources

• Eli Lilly FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3

  Antibody-drug conjugates (ADC), Bispecific antibodies, Digital health · No hiring observed in our sources · 2090 trials (lead sponsor)

• Elpis Biopharmaceuticals

  Bispecific antibodies, Cell therapy, Cell therapy: CAR-T · No hiring observed in our sources

• Eradivir

  Bispecific antibodies, Small molecule · No hiring observed in our sources

• EvolveImmune Therapeutics

  Bispecific antibodies · No hiring observed in our sources

• Fortitude Biomedicines

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Genmab FDA-approved therapeutic company Clinical Phase 3

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 68 trials (lead sponsor)

• GT Biopharma Past trials only

  San Francisco, CA · Bispecific antibodies · No hiring observed in our sources · 1 trial (lead sponsor)

• Hinge Bio, Inc. Clinical Phase 1

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 2 trials (lead sponsor)

• Immatics Biotechnologies Clinical Phase 2

  Bispecific antibodies, Cell therapy, Cell therapy: TCR · No hiring observed in our sources · 7 trials (lead sponsor)

• ImmuVia

  Cambridge, MA · Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources

• Incyte FDA-approved therapeutic company Clinical Phase 3

  Wilmington, DE · Bispecific antibodies, Drug delivery / formulation, Monoclonal antibodies · No hiring observed in our sources · 288 trials (lead sponsor)

• Jazz Pharmaceuticals Clinical Phase 3

  Dublin, · Bispecific antibodies, Monoclonal antibodies, Peptide · No hiring observed in our sources · 206 trials (lead sponsor)

• Kali Therapeutics Clinical Phase 1

  Bispecific antibodies · No hiring observed in our sources · 2 trials (lead sponsor)

• Karyopharm Therapeutics Inc. FDA-approved therapeutic company Clinical Phase 3

  Newton, MA · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 37 trials (lead sponsor)

• Kashiv BioSciences Clinical Phase 3

  Piscataway, NJ · Biosimilars, Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 9 trials (lead sponsor)

• Klus Pharma Clinical Phase 2

  Princeton, NJ · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 4 trials (lead sponsor)

• Kodiak Sciences Clinical Phase 3

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 12 trials (lead sponsor)

• MacroGenics Clinical Phase 3

  Rockville, MD · Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 42 trials (lead sponsor)

• Mirum Pharmaceuticals FDA-approved therapeutic company Clinical Phase 3

  Foster City, CA · Bispecific antibodies, Peptide · No hiring observed in our sources · 39 trials (lead sponsor)

• Mozart Therapeutics

  Seattle, WA · Bispecific antibodies · No hiring observed in our sources

• Navigator Medicines Clinical Phase 2

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 3 trials (lead sponsor)

• NEOK Bio Clinical Phase 1

  Antibody-drug conjugates (ADC), Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 2 trials (lead sponsor)

• NextPoint Therapeutics Clinical Phase 1

  Bispecific antibodies, Monoclonal antibodies · No hiring observed in our sources · 3 trials (lead sponsor)

• OncoTAb

  Charlotte, NC · Bispecific antibodies, Cell therapy, Cell therapy: CAR-T · No hiring observed in our sources

• Oncotherapy Solutions

  Seattle, WA · Antibody-drug conjugates (ADC), Bispecific antibodies, Peptide · No hiring observed in our sources

Showing 60 of 80. Filter in Discover